A binuclear Fe(III) fused porphyrin. Synthesizing the binuclear fused porphyrin includes combining free-base fused-porphyrin and a solvent to yield a solution, refluxing the solution, combining a metal salt with the solution, and removing the solvent from the solution.

A binuclear Fe(III) fused porphyrin. Synthesizing the binuclear fused porphyrin includes combining free-base fused-porphyrin and a solvent to yield a solution, refluxing the solution, combining a metal salt with the solution, and removing the solvent from the solution.

A binuclear Fe(III) fused porphyrin. Synthesizing the binuclear fused porphyrin includes combining free-base fused-porphyrin and a solvent to yield a solution, refluxing the solution, combining a metal salt with the solution, and removing the solvent from the solution.

A binuclear Fe(III) fused porphyrin. Synthesizing the binuclear fused porphyrin includes combining free-base fused-porphyrin and a solvent to yield a solution, refluxing the solution, combining a metal salt with the solution, and removing the solvent from the solution.

A compound, comprising: an Fe(III)-binding and/or Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; and daptomycin covalently bound to the linker, or, if no linker is present, then to the siderophore; or pharmaceutically acceptable salt or solvate thereof.

A compound, comprising: an Fe(III)-binding and/or Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; and daptomycin covalently bound to the linker, or, if no linker is present, then to the siderophore; or pharmaceutically acceptable salt or solvate thereof.

The application relates to a strongly-polarized molecule of the following general formula: wherein A denotes a group having a polarizability greater than 2 C.Math.m.sup.2/V; R.sub.1 and R.sub.2 are respectively hydrogen, halogen, a hydroxyl group, an amino group, a cyano group, a nitro group, a carboxyl group, a C.sub.1-12 alkyl group, a C.sub.1-12 alkoxy group, a halogenated C.sub.1-12 alkyl group, a halogenated C.sub.1-12 alkoxy group, a hydroxyl C.sub.1-12 alkyl group, a hydroxyl C.sub.1-12 alkoxy group, or a C.sub.1-12 alkyl amino group; x.sub.1 and x.sub.2 denote 0 or an integer no less than 1, respectively; and y.sub.1 and y.sub.2 denote 0 or an integer no less than 1, respectively. The application further relates to a strongly-polarized molecule-graphene molecule heterojunction, and a single molecule field effect transistor comprising a substrate, a gate, a dielectric layer and the strongly-polarized molecule-graphene molecule heterojunction; and the dielectric layer is located between the gate and the strongly-polarized molecule-graphene molecule heterojuction. The single molecule field effect transistor provided by the application can realize highly-efficient gate modulation.

##STR00001##

The application relates to a strongly-polarized molecule of the following general formula: wherein A denotes a group having a polarizability greater than 2 C.Math.m.sup.2/V; R.sub.1 and R.sub.2 are respectively hydrogen, halogen, a hydroxyl group, an amino group, a cyano group, a nitro group, a carboxyl group, a C.sub.1-12 alkyl group, a C.sub.1-12 alkoxy group, a halogenated C.sub.1-12 alkyl group, a halogenated C.sub.1-12 alkoxy group, a hydroxyl C.sub.1-12 alkyl group, a hydroxyl C.sub.1-12 alkoxy group, or a C.sub.1-12 alkyl amino group; x.sub.1 and x.sub.2 denote 0 or an integer no less than 1, respectively; and y.sub.1 and y.sub.2 denote 0 or an integer no less than 1, respectively. The application further relates to a strongly-polarized molecule-graphene molecule heterojunction, and a single molecule field effect transistor comprising a substrate, a gate, a dielectric layer and the strongly-polarized molecule-graphene molecule heterojunction; and the dielectric layer is located between the gate and the strongly-polarized molecule-graphene molecule heterojuction. The single molecule field effect transistor provided by the application can realize highly-efficient gate modulation.

##STR00001##

A compound, comprising: an Fe(III)-binding and/or Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; and daptomycin covalently bound to the linker, or, if no linker is present, then to the siderophore; or pharmaceutically acceptable salt or solvate thereof.

The application relates to a strongly-polarized molecule of the following general formula: wherein A denotes a group having a polarizability greater than 2 C.Math.m.sup.2/V; R.sub.1 and R.sub.2 are respectively hydrogen, halogen, a hydroxyl group, an amino group, a cyano group, a nitro group, a carboxyl group, a C.sub.1-12 alkyl group, a C.sub.1-12 alkoxy group, a halogenated C.sub.1-12 alkyl group, a halogenated C.sub.1-12 alkoxy group, a hydroxyl C.sub.1-12 alkyl group, a hydroxyl C.sub.1-12 alkoxy group, or a C.sub.1-12 alkyl amino group; x.sub.1 and x.sub.2 denote 0 or an integer no less than 1, respectively; and y.sub.1 and y.sub.2 denote 0 or an integer no less than 1, respectively. The application further relates to a strongly-polarized molecule-graphene molecule heterojunction, and a single molecule field effect transistor comprising a substrate, a gate, a dielectric layer and the strongly-polarized molecule-graphene molecule heterojunction; and the dielectric layer is located between the gate and the strongly-polarized molecule-graphene molecule heterojunction. The single molecule field effect transistor provided by the application can realize highly-efficient gate modulation. ##STR00001##